Reza Halse

Präsident bei

RA Capital Management LP (Private Equity)

52 Jahre

10 Beziehungen

Health Technology

Commercial Services

Finance

Profil

Reza Halse currently works at Summation Bio, Inc., as Director, CinRx Pharma LLC, as President from 2026, MRL Ventures Fund LLC, as President, Partners Research Ventures & Licensing, as Partner, Droia Ventures, as Partner, and RA Capital Management LP (Private Equity), as President from 2021.
Dr. Halse also formerly worked at TargAnox, Inc., as Chief Executive Officer from 2014 to 2015, Genome Canada, as Chairman from 2013 to 2016, Visterra, Inc., as Director, Novartis Pharmaceuticals, as Associate Director from 2004 to 2008, IOmet Pharma Ltd., as Director, Spero Therapeutics, Inc., as Director, Alector, Inc., as Director, Raze Therapeutics, Inc., as Director, BioMed Valley Discoveries, Inc., as Director from 2008 to 2011, Biocom, Inc., as Member-Governors Board, Partners HealthCare Corp., as Partner from 2012 to 2015, Xcellsyz Ltd., as Head-Cell Biology, Merck Research Ventures, as President from 2017 to 2021, and LAVA Therapeutics NV, as Member-Supervisory Board.
Dr. Halse received his undergraduate degree and doctorate degree from The University of Newcastle.

Aktive Positionen von Reza Halse

Unternehmen	Position	Beginn
Partners Research Ventures & Licensing Partners Research Ventures & Licensing Miscellaneous Commercial ServicesCommercial Services Provides management services	Corporate Officer/Principal	-
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement.	Präsident	01.03.2021
Summation Bio, Inc. Summation Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a novel non-viral gene transfer technology	Direktor/Vorstandsmitglied	-
DROIA NV DROIA NV Investment ManagersFinance Droia Ventures invests in companies located across the globe. The firm focuses on oncology and gentic disease related drug development companies. It provides financing for seed and early stage capital requirements.	Private Equity Investor	-
MRL Ventures Fund LLC MRL Ventures Fund LLC Investment ManagersFinance Operates as a venture capital fund	Präsident	-
CinRx Pharma LLC CinRx Pharma LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company that develops medicines	Präsident	10.02.2026

Alle aktiven Positionen von Reza Halse

Ehemalige bekannte Positionen von Reza Halse

Unternehmen	Position	Ende
Merck Research Ventures Merck Research Ventures Investment ManagersFinance Merck Research invests in companies located globally. The firm targets companies operating in the therapeutics sector. It participates in seed and early stage capital requirements with an investment size of up to USD 25 million. The firm acts as a lead and co-lead investor and takes a seat on the board of directors. It also makes follow-on investments and does not invest in medical devices, diagnostic platforms and digital health.	Präsident	31.03.2021
IOmet Pharma Ltd. IOmet Pharma Ltd. Drugstore ChainsRetail Trade Develops drugs and related products	Direktor/Vorstandsmitglied	21.06.2018
Genome Canada Genome Canada Miscellaneous Commercial ServicesCommercial Services Provides genomic research services	Vorsitzender	30.06.2016
░░░░░░░░ ░░░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Sehen Sie sich die Erfahrung von Reza Halse im Detail an

Ausbildung von Reza Halse

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Reza Halse im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	21
Visterra, Inc. Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
TargAnox, Inc. TargAnox, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to prevent oxidative stress diseases	Health Technology
BIOCOM BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services	Commercial Services
The University of Newcastle The University of Newcastle Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Partners HealthCare Corp. Partners HealthCare Corp. Hospital/Nursing ManagementHealth Services Provides patient care, research, teaching and community services	Health Services
Genome Canada Genome Canada Miscellaneous Commercial ServicesCommercial Services Provides genomic research services	Commercial Services
Novartis Pharmaceuticals Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Xcellsyz Ltd. Xcellsyz Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on discovery of drugs	Commercial Services
Partners Research Ventures & Licensing Partners Research Ventures & Licensing Miscellaneous Commercial ServicesCommercial Services Provides management services	Commercial Services
IOmet Pharma Ltd. IOmet Pharma Ltd. Drugstore ChainsRetail Trade Develops drugs and related products	Retail Trade
Spero Therapeutics, Inc. Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections	Health Technology
Alector, Inc. Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders	Health Technology
Raze Therapeutics, Inc. Raze Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops oncology therapeutics	Health Technology
DROIA NV DROIA NV Investment ManagersFinance Droia Ventures invests in companies located across the globe. The firm focuses on oncology and gentic disease related drug development companies. It provides financing for seed and early stage capital requirements.	Finance
Merck Research Ventures Merck Research Ventures Investment ManagersFinance Merck Research invests in companies located globally. The firm targets companies operating in the therapeutics sector. It participates in seed and early stage capital requirements with an investment size of up to USD 25 million. The firm acts as a lead and co-lead investor and takes a seat on the board of directors. It also makes follow-on investments and does not invest in medical devices, diagnostic platforms and digital health.	Finance
CinRx Pharma LLC CinRx Pharma LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company that develops medicines	Commercial Services
MRL Ventures Fund LLC MRL Ventures Fund LLC Investment ManagersFinance Operates as a venture capital fund	Finance
BioMed Valley Discoveries, Inc. BioMed Valley Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops therapies for cancer, inflammation and infectious disease	Commercial Services
LAVA Therapeutics NV LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer	Health Technology
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement.	Finance
Summation Bio, Inc. Summation Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a novel non-viral gene transfer technology	Commercial Services